69
Views
9
CrossRef citations to date
0
Altmetric
Drug Profile

Thalidomide: present and future in multiple myeloma

Pages 25-31 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mohamad A Hussein. (2006) Pharmacotherapy of multiple myeloma. Expert Opinion on Pharmacotherapy 7:6, pages 767-781.
Read now

Articles from other publishers (8)

Michael A. Firer, Michael Y. Shapira & Galia Luboshits. (2021) The Impact of Induction Regimes on Immune Responses in Patients with Multiple Myeloma. Cancers 13:16, pages 4090.
Crossref
Ibrahim Yakoub‐Agha, Jean‐Yves Mary, Cyrille Hulin, Chantal Doyen, Gérald Marit, Lotfi Benboubker, Laurent Voillat, Philippe Moreau, Christian Berthou, Anne‐Marie Stoppa, Frédéric Maloisel, Philippe Rodon, Mamoun Dib, Brigitte Pegourie, Philippe Casassus, Borhane Slama, Ghandi Damaj, Robert Zerbib, Jean‐Luc Harousseau, Mohamad Mohty & Thierry Facon. (2012) Low‐dose vs. high‐dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome. European Journal of Haematology 88:3, pages 249-259.
Crossref
Yang Shen, Zhixiang Shen, Bin Jiang, Jian Hou, Rong Zhan, Lugui Qiu, Daobin Zhou, Jie Jin, Juan Li, Fanyi Meng, Ping Zou, Ting Liu, Jianyong Li, Chun Wang, Depei Wu & Jun Ma. (2010) An open-label study of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients in the Chinese population. Clinical Oncology and Cancer Research 6:6, pages 394-400.
Crossref
J. Kay Noel, Sheila Crean, Janet E. Claflin, Gayatri Ranganathan, Heather Linz & Michael Lahn. (2008) Systematic review to establish the safety profiles for direct and indirect inhibitors of p38 Mitogen-activated protein kinases for treatment of cancer. Medical Oncology 25:3, pages 323-330.
Crossref
Mohamad A. Hussein. (2007) Preclinical Rationale, Mechanisms of Action, and Clinical Activity of Anthracyclines in Myeloma. Clinical Lymphoma and Myeloma 7, pages S145-S149.
Crossref
Peter H. Wiernik. (2006) Plasma cell dyscrasias and leukemias. Update on Cancer Therapeutics 1:4, pages 539-567.
Crossref
Mohamad A. Hussein, Rachid Baz, Gordan Srkalovic, Neeraj Agrawal, Revathi Suppiah, Eric Hsi, Steven Andresen, Mary Ann Karam, Janice Reed, Beth Faiman, Megan Kelly & Esteban Walker. (2006) Phase 2 Study of Pegylated Liposomal Doxorubicin, Vincristine, Decreased-Frequency Dexamethasone, and Thalidomide in Newly Diagnosed and Relapsed-Refractory Multiple Myeloma. Mayo Clinic Proceedings 81:7, pages 889-895.
Crossref
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:2, pages 89-96.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.